Global Urolithiasis Management Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• January 2022, the FDA designated Applaud Medical's Acoustic Enhancer technology as a breakthrough product, according to an announcement. Applaud Medical, a San Francisco-based company, created an Acoustic Enhancer technology for use with ureteroscopy with laser lithotripsy (URS-LL) to divide calcium-based urinary stones that are obstructing or that a urologist or other qualified medical professional determines to pose a significant risk of future hindrance and are at least 6mm in diameter but not larger than 20mm.

• March 2021, Boston Scientific and a Baring Private Equity Asia (BPEA) unit inked a legally binding agreement for Boston Scientific to pay USD 1.07 billion in cash upfront to purchase Lumenis' global surgical business. This acquisition allowed Boston Scientific to expand its kidney stone management products globally.

• June 2020, Olympus Corporation introduced the Soltive Laser System, a new thulium fiber laser application created for soft tissue applications and stone lithotripsy.

Urolithiasis, commonly known as kidney stones, presents a significant healthcare challenge worldwide due to its prevalence and potential complications. The global market for urolithiasis management devices encompasses a wide range of tools and technologies aimed at diagnosis, treatment, and prevention. This market is expected to experience robust growth driven by factors such as rising incidence of urolithiasis, technological advancements in minimally invasive procedures, and increasing awareness about preventive measures among patients and healthcare professionals.

Diagnostic devices play a crucial role in identifying the presence, size, and composition of kidney stones. Advancements in imaging modalities such as ultrasound, CT scans, and MRI have greatly enhanced the accuracy and efficiency of diagnosis. Additionally, the development of portable and handheld diagnostic devices has facilitated early detection and monitoring of urolithiasis, further driving market growth.

Treatment devices for urolithiasis include lithotripters, ureteroscopes, and stone retrieval devices. Lithotripsy, a non-invasive procedure that uses shock waves to break down kidney stones, remains a cornerstone of urolithiasis management. However, there is a growing preference for minimally invasive techniques such as ureteroscopy and percutaneous nephrolithotomy (PCNL), which offer higher success rates and shorter recovery times. Manufacturers are investing in the development of advanced lithotripsy systems and innovative stone retrieval devices to meet the evolving needs of patients and healthcare providers.

Preventive devices and tools are also gaining traction in the urolithiasis management market. These include dietary supplements, hydration monitoring devices, and mobile applications designed to promote healthy lifestyle choices and prevent stone recurrence. With increasing emphasis on patient education and proactive management strategies, the demand for preventive devices is expected to rise, driving market expansion in the coming years.

Global Urolithiasis Management Devices Segment Analysis

In this report, the Global Urolithiasis Management Devices Market has been segmented by Treatment Type, End Use and Geography.

Global Urolithiasis Management Devices Market, Segmentation by Treatment Type

The Global Urolithiasis Management Devices Market has been segmented by Treatment Type into Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Others.

Extracorporeal Shock Wave Lithotripsy (ESWL) is one of the primary treatment modalities for kidney stones. This non-invasive procedure utilizes shock waves to fragment stones into smaller pieces, which can then be passed naturally through the urinary tract. ESWL is preferred for smaller stones located in the kidney or ureter, offering a less invasive alternative to surgery and shorter recovery times for patients.

Intracorporeal Lithotripsy involves the use of devices to break down kidney stones from within the body. This approach is particularly suitable for larger or more complex stones that cannot be effectively treated with ESWL alone. Techniques such as laser lithotripsy and pneumatic lithotripsy are commonly employed to fragment stones into smaller pieces, facilitating their removal through minimally invasive procedures.

Percutaneous Nephrolithotomy (PCNL) is a surgical procedure used to remove large kidney stones or stones that cannot be effectively treated using non-invasive methods. During PCNL, a small incision is made in the back, allowing access to the kidney to remove stones directly. This approach is especially beneficial for patients with complex or multiple stones, offering high success rates and reduced risk of recurrence.

Other treatment modalities for urolithiasis management include emerging techniques and devices aimed at improving treatment efficacy and patient outcomes. These may include advanced imaging technologies for precise stone localization, novel surgical approaches for complex cases, and innovative devices for stone fragmentation and removal. With ongoing research and development efforts, the landscape of urolithiasis management is continually evolving, providing patients with more effective and less invasive treatment options.

Global Urolithiasis Management Devices Market, Segmentation by End Use

The Global Urolithiasis Management Devices Market has been segmented by End Use into Hospitals & Clinics and Ambulatory Surgical Centers.

Hospitals and clinics represent the primary end users of urolithiasis management devices. These facilities cater to a broad spectrum of patients with varying degrees of urolithiasis complexity, ranging from simple cases to severe complications requiring surgical intervention. Hospitals, equipped with advanced diagnostic and treatment technologies, serve as comprehensive centers for urolithiasis management, offering patients access to a full range of services, including lithotripsy, ureteroscopy, and minimally invasive surgeries.

Ambulatory surgical centers (ASCs) constitute another important segment in the urolithiasis management devices market. These facilities provide outpatient surgical procedures, offering convenience, cost-effectiveness, and reduced hospitalization duration for patients requiring urolithiasis treatment. ASCs are increasingly preferred for their streamlined processes, specialized care, and shorter wait times, making them an attractive option for individuals seeking prompt and efficient management of urinary stones.

The segmentation of the urolithiasis management devices market by end use reflects the diverse healthcare settings where patients receive treatment for urinary stones. While hospitals and clinics remain the cornerstone of urolithiasis care, ambulatory surgical centers play a complementary role in meeting the growing demand for outpatient procedures and enhancing patient accessibility to timely and effective urolithiasis management services. As healthcare delivery models continue to evolve, the collaboration between these two end-use segments is expected to contribute to the expansion and improvement of urolithiasis treatment options globally.

Global Urolithiasis Management Devices Market, Segmentation by Geography

In this report, the Global Urolithiasis Management Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Urolithiasis Management Devices Market Share (%), by Geographical Region, 2024

North America holds a prominent position in this market owing to factors such as high prevalence of urolithiasis, advanced healthcare infrastructure, and increasing adoption of minimally invasive surgical procedures. Additionally, the presence of key market players and ongoing research and development activities further contribute to the growth of this region.

Europe follows North America in terms of market share, driven by increasing awareness regarding urolithiasis management, technological advancements in treatment options, and supportive government initiatives. The presence of a large patient pool and well-established healthcare facilities in countries like Germany, the UK, and France also fuels market growth in this region.

The Asia Pacific region is expected to witness rapid growth during the forecast period due to factors such as rising healthcare expenditure, improving healthcare infrastructure, and increasing prevalence of urolithiasis. Moreover, the growing adoption of advanced medical devices and procedures, coupled with expanding healthcare facilities in countries like China, India, and Japan, further contribute to the market expansion in this region.

In the Middle East and Africa, the market for urolithiasis management devices is primarily driven by increasing healthcare investments, rising awareness regarding urolithiasis, and the presence of a large patient pool. However, limited access to healthcare facilities in certain areas and economic constraints may hinder market growth to some extent.

Latin America also presents opportunities for market growth, propelled by improving healthcare infrastructure, rising disposable income, and increasing prevalence of urolithiasis. However, challenges such as regulatory hurdles and limited access to advanced healthcare facilities in rural areas could impede market expansion in this region.

This report provides an in depth analysis of various factors that impact the dynamics of Global Urolithiasis Management Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers

• Technological advancements
• Increasing prevalence of kidney stones
• Growing demand for minimally invasive procedures

• Rising awareness about urological disorders: The global urolithiasis management devices market is experiencing significant growth, primarily driven by the rising awareness about urological disorders among both patients and healthcare professionals. Urolithiasis, commonly known as kidney stones, is a prevalent condition affecting millions worldwide. As awareness about this condition increases, individuals are more proactive in seeking diagnosis and treatment options, leading to a surge in the demand for urolithiasis management devices.

  Advancements in medical technology have led to the development of innovative devices for the management of urolithiasis. These devices range from minimally invasive procedures such as lithotripsy and ureteroscopy to more complex surgical interventions. The growing adoption of these devices is further fueled by their efficacy in treating urolithiasis with reduced complications and improved patient outcomes.

  Factors such as the increasing prevalence of risk factors like obesity and unhealthy dietary habits contribute to the rising incidence of urolithiasis globally. This, coupled with the aging population and the growing burden of chronic kidney diseases, underscores the need for effective urolithiasis management devices. As a result, healthcare providers are focusing on expanding their product portfolios and improving access to these devices, thereby driving the growth of the global urolithiasis management devices market.

Restraints

• High cost of treatment
• Lack of skilled professionals
• Stringent regulatory guidelines

• Limited access to healthcare facilities: The global urolithiasis management devices market faces a significant challenge due to limited access to healthcare facilities, particularly in developing regions. Urolithiasis, commonly known as kidney stones, requires prompt diagnosis and treatment to prevent complications such as kidney damage and urinary tract infections. However, in many parts of the world, access to specialized healthcare services and advanced medical devices for urolithiasis management is limited or unavailable.

  This lack of access to healthcare facilities exacerbates the burden of urolithiasis on affected individuals and healthcare systems. Patients in underserved areas may experience delays in diagnosis and treatment, leading to prolonged pain and discomfort. Moreover, without access to appropriate medical interventions, individuals with urolithiasis are at a higher risk of developing complications that may require more extensive and costly medical interventions in the long run.

  Addressing the issue of limited access to healthcare facilities for urolithiasis management requires collaborative efforts from governments, healthcare organizations, and medical device manufacturers. Initiatives aimed at improving healthcare infrastructure, training healthcare professionals in urolithiasis management, and increasing the availability of affordable medical devices can help bridge the gap in access to care. By prioritizing investments in healthcare infrastructure and expanding healthcare services to underserved populations, stakeholders can work towards ensuring timely diagnosis and treatment for individuals affected by urolithiasis, ultimately improving patient outcomes and reducing the burden on healthcare systems.

Opportunities

• Emerging markets in Asia-Pacific
• Development of innovative urology devices
• Strategic collaborations and partnerships

• Rising adoption of lithotripsy devices: The global urolithiasis management devices market is witnessing a significant surge in the adoption of lithotripsy devices, driven by several key factors. Lithotripsy, a non-invasive procedure for breaking down kidney stones, has gained popularity due to its efficacy, minimal invasiveness, and reduced recovery time compared to traditional surgical methods. This rise in adoption can be attributed to the growing prevalence of urolithiasis worldwide, fueled by factors such as sedentary lifestyles, unhealthy dietary habits, and increasing obesity rates.

  Technological advancements in lithotripsy devices have enhanced their efficacy and safety profiles, making them more attractive to both healthcare providers and patients. Innovations such as extracorporeal shock wave lithotripsy (ESWL) and laser lithotripsy have revolutionized the treatment landscape, offering precision, faster stone fragmentation, and reduced risk of complications. Additionally, the availability of portable and compact lithotripsy devices has expanded treatment accessibility, particularly in remote or underserved regions where access to specialized healthcare facilities may be limited.

  The rising preference for minimally invasive procedures among patients, coupled with the increasing adoption of advanced healthcare technologies by healthcare providers, is driving the demand for lithotripsy devices. Minimally invasive procedures offer benefits such as shorter hospital stays, quicker recovery times, and lower risk of post-operative complications, leading to improved patient outcomes and satisfaction. As healthcare systems strive to optimize resource utilization and reduce healthcare costs, lithotripsy devices present a compelling solution for the management of urolithiasis, offering both clinical and economic advantages.

Key players in Global Urolithiasis Management Devices Market include:

• Boston Scientific Corporation
• Cook Medical
• Olympus Corporation
• C. R. Bard, Inc
• Dornier MedTech
• Richard Wolf GmbH
• Stryker Corporation
• Karl Storz SE & Co. KG
• Medtronic plc
• Coloplast Group

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis